InsidersTradesSigma
Follow the Lipigon Pharmaceuticals AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Lipigon Pharmaceuticals AB has logged 3 reports. Market capitalisation: €909k. The latest transaction was disclosed on 27 May 2025 (Purchase). Among the most active insiders: Fredrik Lindgren. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Lipigon Pharmaceuticals AB is a biopharmaceutical company focused on developing treatments for metabolic diseases. It is listed on the Stockholm Stock Exchange (XSTO).